EPISARS

Prevention of future SARS epidemics through the control of animal and human infection



 

 


 

Institut Pasteur

 


Institution

The Institut Pasteur is involved with the study of infectious, parasitic and immune-system diseases. It brings together three fields of activity, namely research, education and public health – at its Parisian campus with almost 2500 individuals.


Institut Pasteur has a long-lasting experience in monitoring data about infectious diseases and in providing advice on health policies pertaining to these diseases through the 22 French National Reference Centres and 9 WHO Collaborating Centres located on its premises and embedded within the Research Units (e.g., influenza, tuberculosis, salmonellosis, listeriosis, West Nile virus infections, etc…).


At the European level, the Institut Pasteur contributes to several networks on infectious diseases (e.g., influenza, tuberculosis, salmonellosis and other bacterial enteritic infections, etc…), and harbours the coordination of EuroGROG a scheme focused on influenza, which has been funded by the EU since 2000.


In addition, the International Network of Pasteur Institutes constitutes an original and autonomous body providing services in terms of monitoring infectious diseases throughout the world in collaboration with WHO.

 

  Top

 

Participants

The Emerging Diseases Epidemiology Unit has been created in 2001 and has collaborative projects with developing countries. One project on hepatitis C virus (HCV) in Egypt is supported by the EC, others projects on AIDS are developed through the International Network of the Pasteur Institutes in Asia and in Africa. The group is composed by 4 senior researchers, one post-doctoral staff, two PhD students, a public health resident and a data manager.
Dr Arnaud Fontanet leads this group. He was trained as a medical doctor in France, and got his PhD in the epidemiology of infectious diseases at the Harvard School of Public Health. He has since worked in the field of infectious and tropical diseases in Asia and Africa, and has followed several cohort studies on HIV and HCV. From 1994 to 1999, he has been the expatriate Project Manager of the Ethio-Netherlands AIDS Research Project, a multidisciplinary research project on AIDS in Addis Ababa, Ethiopia, with more than 30 scientific publications in international peer-reviewed journals. Since 2000, he is the P.I. and scientific coordinator of three international and multidisciplinary research projects on HCV in Egypt.
Dr Laurence Baril is a specialist in infectious diseases that has also been trained in clinical epidemiology. She worked in Paris at the HIV Research Unit (Hôpital de la Pitié-Salpêtrière, University of Paris 6) where LI Taisheng (WP 9) did his Ph.D in clinical immunology. Before going back to an academic setting in March 2003, she worked in R&D for vaccine development at Aventis-Pasteur during 4 years. Both Arnaud Fontanet (in May and July 2003) and Laurence Baril (in May 2003) travelled to China on expert missions to initiate this collaborative research project on SARS.


The Cellule d'Intervention Biologique d'Urgence (Laboratory for Emergency Response to Biological Threat), created in 2001, harbours the Centre d'Identification Moléculaire des Virus (Centre for Molecular Identification of Viruses) and is led by Jean-Claude Manuguerra. He was originally trained as a veterinary and got his PhD in virology before becoming a specialist in influenza viruses. As such, he is the leader of the PanEuropean system for the surveillance of influenza in humans, named EuroGROG, and a member of the steering committee of the EU funded European Influenza Surveillance Scheme. He is co-director of the National Influenza Centre for Northern France and of the WHO collaborative Centre for Research and Reference on Influenza Viruses and Other Respiratory Viruses, one of the 13 laboratories included in the WHO Collaborative Multi-Centre Laboratory Network on SARS. He shares the directorships of these centres with Pr Sylvie van der Werf, who leads the Unit of Molecular Genetics of Respiratory Viruses, harbouring these centres. Jean-Claude Manuguerra belongs to the French team sent to Hanoi for the control of the SARS outbreak at the Franco-Vietnamese Hospital in March 2003. He also went on mission to China on two occasions (May and July 2003) to initiate this collaborative project.

 

Participation of women: Laurence Baril, one of the senior researchers.

 

  Top

 

Roles in the project

  • Administrative and scientific project coordination by Dr Arnaud Fontanet (leader of the WP 12 to 14).
  • Expertise in clinical epidemiology (methodology, statistical analysis) and collaborative applied research on infectious diseases by Arnaud Fontanet and Laurence Baril (participants to the WP 6, 7, 9)
  • Expertise in basic and applied research on respiratory viruses by Jean-Claude Manuguerra (leader of the WP 3 and participant to the WP 7 and 13).
  Top

 

Publications

5 recent publications:


1. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, Laman JD, de Jong
T, van Doornum G, Lim W, Ling AE, Chan PK, Tam JS, Zambon MC, Gopal R, Drosten C, van der Werf S,
Escriou N, Manuguerra JC, Stohr K, Peiris JS, Osterhaus AD. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263-70

2. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova
L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S,
Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW.
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New Engl J Med
2003;348:1967-76

3. Manuguerra JC, Mosnier A, Paget WJ; EISS (European Influenza Surveillance Scheme). Monitoring of influenza in the EISS European network member countries from October 2000 to April 2001.Euro Surveill.
2001;6:127-35.

4. Mekonnen Y, Dukers NHTM, Sanders E, Dorigo W, Wolday D, Schaap A, Geskus RB, Coutinho RA,
Fontanet AL. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS,
2003;17:815-9.

5. Mekonnen Y, Sanders E, Aklilu M, Tsegaye A, Rinke de Wit TF, Schaap A, Wolday D, Geskus R, Coutinho
RA, Fontanet AL. Evidence of changes in sexual behaviours among male factory workers in Ethiopia. AIDS,
2003;17:1-9.


  Top

 

 

 


For any questions or suggestions, please contact the webmaster : Marie-Hélène Chang